I-Canagliflozin

Incazelo emfushane:

Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
I-Canagliflozin Isifo sikashukela sohlobo 2 Endlini    


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

Ingemuva

I-Canagliflozin inoveli, inamandla, futhi ikhetha kakhulu i-sodium glucose co-transporter (SGLT) 2 inhibitor [1]. Kufakazelwe ukuthi i-Canagliflozin ingakhuphula ukuphuma kwe-glucose yomchamo ngokunciphisa umkhawulo we-glucose ezinso kanye nokunciphisa ukumuncwa kabusha kwe-glucose ehlungiwe.

I-Canagliflozin iboniswe ukuthi ivimbela ukungena kwe-Na+-mediated 14C-AMG ku-CHO-hSGLT2, CHO-rat SGLT2 kanye ne-CHO-mouse SGLT2 ngamavelu e-IC50 angu-4.4, 3.7 kanye no-2.0 nM, ngokulandelana [1].

I-Canagliflozin kubikwe ukuthi yehlisa amazinga eglucose yegazi (BG) ngokuncika kumthamo kuwo womabili Amagundane e-db/db kanye ne-Zucker Diabetic Fatty (ZDF) Rats. Ukwengeza, i-canagliflozin ibonakale yehlisa isilinganiso sokushintshana kokuphefumula, nesisindo somzimba kumagundane e-DIO namagundane e-ZDF [1].

I-Canagliflozin ingathathwa ngomlomo [1].

Izithenjwa:
[1] U-Liang Y1, Arakawa K, Ueta K, Matsushita Y, Kuriyama C Martin T, Du F, Liu Y, Xu J, Conway B, Conway J, Polidori D, Ways K, Demarest K. Umphumela we-canagliflozin embundwini wezinso ye-glucose, i-glycemia, nesisindo somzimba kumamodeli ezilwane ezijwayelekile nezinesifo sikashukela. I-PLoS One. 2012;7(2):e30555
[2] Sarnoski-Brocavich S, Hilas O. Canagliflozin (Invokana), I-ejenti Yomlomo Yenoveli Yohlobo Lwesifo Sikashukela. P T. 2013 Nov;38(11):656-66

Ukucaphuna Komkhiqizo

Bahia Abbas Moussa, Marianne Alphonse Mahrouse, et al. "Izindlela zokuxazulula ezihlukene zokuphatha i-spectra egqagqene: Isicelo sokunqunywa kwezidakamizwa ze-hypoglycemic ezinoveli ezakhiwe ngokuhlanganyela efomini lazo lemithamo ehlanganisiwe yemithi." I-Spectrochimica Acta Ingxenye A: I-Molecular and Biomolecular Spectroscopy Itholakala ku-inthanethi zingama-20 kuJuni 2018.

Isakhiwo samakhemikhali

I-Canagliflozin

ISItifiketi

2018 GMP-2
原料药GMP证书201811 (captopril,thalidomide njll)
I-GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
I-FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Ukuphathwa kwekhwalithi1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Ukuphathwa kwekhwalithi2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Ukuphathwa kwekhwalithi3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Ukuphathwa kwekhwalithi4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
Ukubambisana kwamazwe ngamazwe
Ukubambisana kwasekhaya
Ukubambisana kwasekhaya

  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona